• SENSEX 75,408.69
    949.16 (+1.27%)
  • BANKNIFTY 54,686.95
    -222.70 (--0.41%)
  • Reliance Industries
    1,266.50 1,611.20(%)
  • Jio Platforms
    1,476.15 1,490.00(%)
  • NSE
    1,773.30 1,640.25(%)
  • JSW Steel
    1,310.95 1,350.30(%)
  • Billionbrains
    196.65 227.00(%)
  • Dixon Technolog.
    12,490.00 15,773.95(%)
  • PB Fintech.
    926.00 945.00(%)
  • Aster DM Quality
    673.00 519.80(%)
  • Shriram Finance
    871.25 1,153.65(%)
  • Welspun Living
    243.20 245.70(%)
  • PTC Industries
    24,495.70 26,049.95(%)
  • Rubicon Research
    1,704.65 1,896.15(%)
  • Avenue Super.
    3,218.80 4,642.00(%)
  • Coforge
    2,111.20 2,061.90(%)
  • Netweb Technol.
    3,992.00 2,942.45(%)
  • Cupid
    341.00 369.70(%)
  • Alivus Life
    1,504.00 1,497.00(%)
  • Max Healthcare
    905.35 1,196.50(%)
  • Nippon ETF Liq.
    995.01 978.01(%)
  • Zen Technologies
    1,805.00 2,041.90(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Anuh Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 2916.0
  • ISIN : INE489G01022
87.31 8 (9.49%)
  • As on 02 Nov 2026 (EOD)

  • Today’s Low

    79.07

  • Today’s High

    89.80

  • Open

    80.50

  • Perv Close

    79.74

  • 52W Low

    67.00

  • 52W High

    99.50

Key Indicators

  • P/E(TTM)

    19.75

  • Mar.Cap (₹Cr.)

    875.06

  • Div & Yield %

    1.72

  • Book Value(₹)

    35.14

  • Debt-Equity Ratio

    9.49

  • AGM Date

    30-Oct-2026

  • EPS

    4.41

  • P/E Ratio

    19.75

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    875.06

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    50.11

  • BV (₹)

    35.10

  • Sales( ₹ in Cr.)

    771.66

  • NP (in Cr.)

    36.32

  • NP Var(%)

    -3.0

  • Div%

    30.0

  • CPS (₹)

    4.80

  • EPS (₹)

    3.60

  • Traded Value (₹ in Lakhs)

    872.85

  • 52 Week High

    99.50

  • 52 Week Low

    67.00

  • Price BSE

    87.0

  • Price NSE

    87.00

  • Market Capital( in Cr.)

    872.85

  • P/C Ratio

    18.30

  • P/E Ratio

    24.00

  • Price Vs.BV

    3.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 771.66 661.51 647.00 527.49 486.65 431.96
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 771.66 661.51 647.00 527.49 486.65 431.96
Other Income 4.36 9.46 12.10 6.11 5.20 10.54
Stock Adjustments -10.02 2.45 15.24 -13.48 4.86 -2.31
Total Income 766.00 673.42 674.34 520.12 496.71 440.19
EXPENDITURE :            
Raw Materials 589.18 501.42 501.90 388.00 382.54 327.49
Power and Fuel Cost 13.44 12.35 12.37 11.02 8.80 8.66
Employee Cost 26.30 23.04 19.39 17.15 15.10 14.29
Other Manufacturing Expenses 40.65 39.35 23.72 19.98 14.91 13.41
Selling and Administration Expenses 18.54 17.44 15.50 13.28 12.07 11.17
Miscellaneous Expenses 11.32 8.84 13.61 12.77 10.62 9.51
Employee Benefit Expenses 26.30 23.04 19.39 17.15 15.10 14.29
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 699.44 602.44 586.49 462.20 444.04 384.53
Operating Profit 66.56 70.98 87.85 57.92 52.66 55.66
Interest 0.96 1.24 0.96 0.75 1.58 2.03
Gross Profit 65.60 69.74 86.89 57.17 51.08 53.63
Depreciation 11.38 8.74 8.58 9.70 11.96 15.08
Profit Before Tax 54.22 61.00 78.31 47.47 39.12 38.55
Current Tax 15.18 14.67 18.13 12.12 10.58 9.47
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -2.01 -1.02 0.12 -0.83 -2.02 0.65
Reported Net Profit 41.05 47.35 60.06 36.18 30.56 28.44
Extraordinary Items 4.73 9.73 8.17 3.24 1.97 5.94
Adjusted Net Profit 36.32 37.62 51.89 32.94 28.59 22.50
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 184.45 156.63 113.59 93.18 76.14 53.70
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 22.03 19.53 17.02 15.77 13.52 6.00
P & L Balance carried down 203.47 184.45 156.63 113.59 93.18 76.14
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 30.00 30.00 50.00 40.00 35.00 30.00
Dividend Per Share(Rs) 1.50 1.50 2.50 2.00 1.75 1.50
Earnings Per Share-Unit Curr 4.10 9.45 11.98 7.22 6.10 5.67
Earnings Per Share(Adj)-Unit Curr 4.10 4.73 5.99 3.61 3.05 2.84
Book Value 35.14 65.06 58.11 48.14 42.66 38.04
Book Value(Adj)-Unit Curr 35.14 32.53 29.06 24.07 21.33 19.02

Shareholding Pattern

  • Promoter Group

    71.80%

  • Public Share Holding

    28.20%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 14,400 14,400.00 14,400 14,400
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 14,400 0.01 14,400 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 191,688 0.19 191,688 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 34,133,948 34.06 34,133,948 18
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 37,371,368 37.29 37,371,368 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 244,640 0.24 244,640 7
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 71,941,644 71.78 71,941,644 36
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 300 0.00 300 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 112,459 0.11 112,459 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,150 0.00 1,150 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 113,909 0.11 113,909 5
2] Non Institution
Bodies Corporate 795,887 0.79 767,087 97
Clearing Members 46,051 0.05 46,051 11
Directors of their Relatives 12,906 0.01 12,906 3
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,540,051 2.53 2,540,051 513
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,198,423 1.20 1,198,423 591
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 6,377,307 6.36 6,319,707 73
Individuals holding nominal share capital up to Rs. 1 lakh 16,842,417 16.80 16,722,801 27,114
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 134,944 0.13 134,944 1
Sub Total 28,154,047 28.09 27,948,031 28,405
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 100,224,000 100.00 100,017,984 28,447

Company Background

Anuh Pharma LtdPharmaceuticals - Indian - Bulk Drugs

  • Anuh Pharma Ltd
  • BSE Code : 2916.0
  • ISIN : INE489G01022

  • Incorporation Year

    1960

  • Registered Office

    3-A Shivsagar Estate
    North Wing Dr A B Road Worli, Mumbai,
    Maharashtra-400018

  • Telephone

    91-22-6622 7575

  • FAX

    91-22-6622 7600

  • Chairman

    Arun Todarwal

  • Managing Director

    Ritesh B Shah

  • Company Secretary

    Manan Jayesh Vadhan

  • Auditor

    Jayantilal Thakkar & Co

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    BigShare Services Pvt Ltd
    J/12 Ansa Indl Est,
    Sakivihar Road,Sakinaka Andheri (E)
    Mumbai - Mumbai - 400072

Anuh Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Anuh Pharma 87.09 776.01 771.66 19.75 15.92
Abbott India 25,593.30 7,217.19 6,929.05 33.68 43.78
Astrazeneca Phar 6,367.35 2,304.07 2,275.58 93.84 27.86
Glaxosmi. Pharma 2,483.55 3,932.76 3,790.20 39.67 58.17
Novartis India 1,693.85 393.10 354.33 42.77 15.94
Cipla 1,380.00 20,102.60 18,979.95 42.06 13.88
Bliss GVS Pharma 648.40 773.53 729.81 60.26 12.51
Amrutanjan Healt 496.85 520.13 502.55 26.61 24.16
Fermenta Biotec. 417.55 474.15 450.25 19.49 18.77
Guj. Themis Bio. 362.50 168.25 165.82 96.93 18.05
Ambalal Sarabhai 35.00 19.52 3.94 64.81 6.77